HDT Bio
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever Vaccine, Crimean-Congo Hemorrhagic Fever | Phase 1 | 2025-07-10 |
| Completed | Safety and Immunogenicity of HDT-301 Targeting a SARS-CoV-2 Variant Spike Protein SARS-CoV2 Infection | Phase 1 | 2022-01-24 |